Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report

Cited by (1,000)

Items 501–600 of 1,000

1. Vaccination against β-Amyloid as a Strategy for the Prevention of Alzheimer’s Disease
   Mantile, Francesca, Prisco, Antonella · 2020 · Biology
2. Current Issues in the Treatment of Human Diseases by Mucosal Tolerance
   Howard L. Weiner · 2004 · Annals of the New York Academy of Sciences
3. The companion dog as a unique translational model for aging
   Andrea Mazzatenta, Augusto Carluccio, Domenico Robbe, Camillo Di Giulio, Alessandro Cellerino · 2017 · Seminars in Cell and Developmental Biology
4. Pharmacotherapeutic targets in Alzheimer's disease
   Yif'at Biran, Colin Louis Masters, Kevin Jeffrey Barnham, Ashley Ian Bush, Paul Anthony Adlard · 2008 · Journal of Cellular and Molecular Medicine
5. Imaging Alzheimer's disease pathology: one target, many ligands
   Andrew Lockhart · 2006 · Drug Discovery Today
6. Antibody-Mediated Clearance of Amyloid-β Peptide from Cerebral Amyloid Angiopathy Revealed by QuantitativeIn VivoImaging
   Claudia M. Prada, Mónica Garcı́a-Alloza, Rebecca A. Betensky, Sandy Zhang-Nunes, Steven Mark Greenberg, Brian J. Bacskai, Matthew P. Frosch · 2007 · Journal of Neuroscience
7. Soluble Amyloid Precursor Protein 770 Is Released from Inflamed Endothelial Cells and Activated Platelets
   Shinobu Kitazume, Akiomi Yoshihisa, Takayoshi Yamaki, Masayoshi Oikawa, Yuriko Tachida, Kazuko Ogawa, Rie Imamaki, Yoshiaki Hagiwara, Noriaki Kinoshita, Yasuchika Takeishi et al. · 2012 · Journal of Biological Chemistry
8. Cerebral Amyloid Angiopathy, Subcortical White Matter Disease and Dementia: Literature Review and Study in OPTIMA
   Margaret M. Esiri, Steven Andrew Chance, Catharine L. Joachim, Donald R. Warden, Aidan Smallwood, Carolyn Sloan, Sharon Christie, Gordon Keith Wilcock, A. David Smith · 2014 · Brain Pathology
9. Targeting tauopathy with engineered tau-degrading intrabodies
   Gilbert Gallardo, Connie Hau Yan Wong, Sara M. Ricardez Hernandez, Carolyn N. Mann, Kent Lin, Cheryl E. G. Leyns, Hong Jiang, David M. Holtzman · 2019 · Molecular Neurodegeneration
10. Dendrimeric Aβ1–15 is an effective immunogen in wildtype and APP-tg mice
    Timothy J. Seabrook, Katelyn Thomas, Liying Jiang, Jeanne K. Bloom, Edward Spooner, Marcel Maier, Gal Bitan, Cynthia Ann Lemere · 2006 · Neurobiology of Aging
11. Neuroinflammation in Alzheimer's disease: protector or promoter?
    Norbert Žilka, M Ferencĭk, I Hulín · 2006 · Bratislavské lekárske listy/Bratislava medical journal
12. Towards Practical Cognitive Assessment for Detection of Early Dementia: A 30-Minute Computerized Battery Discriminates as Well as Longer Testing
    Glen M. Doniger, David M. Zucker, Avraham Schweiger, Tzvi Dwolatzky, Howard Mark Chertkow, Howard Crystal, Ely S. Simon · 2005 · Current Alzheimer Research
13. Amelioration of amyloid load by anti-Aβ single-chain antibody in Alzheimer mouse model
    Ken‐ichiro Fukuchi, Mary Ann Accavitti-Loper, Hong Duck Kim, Kazuki Tahara, Yunpeng Cao, Terry L. Lewis, Robert C. Caughey, Helen Kim, Robert Lalonde · 2006 · Biochemical and Biophysical Research Communications
14. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease
    Hong‐Duck Kim, Jing-Ji Jin, J. Adam Maxwell, Ken-ichiro Fukuchi · 2007 · Immunology Letters
15. Pharmacotherapy of Alzheimer Disease
    Dennis Chuen Chai Seow, Serge G. Gauthier · 2007 · The Canadian Journal of Psychiatry
16. Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer’s disease
    Malú G. Tansey, McAlpine · 2008 · Journal of Inflammation Research
17. Immunological and Anti-Chaperone Therapeutic Approaches for Alzheimer Disease
    Thomas Wısnıewskı, Blas Frangione · 2006 · Brain Pathology
18. Generation and characterization of the humoral immune response to DNA immunization with a chimeric β‐amyloid‐interleukin‐4 minigene
    Anahit Ghochikyan, Vitaly Vasilevko, Irina Petrushina, Nina Movsesyan, Davit Babikyan, Wenqiang Tian, Nadya Sadzikava, Ted M. Ross, Elizabeth Head, David H. Cribbs et al. · 2003 · European Journal of Immunology
19. Cerebral amyloid angiopathy and related inflammatory disorders
    Bart K. Chwalisz · 2021 · Journal of the Neurological Sciences
20. Immunotherapy as a therapeutic treatment for neurodegenerative disorders
    Anthony Robert White, Simon H Hawke · 2003 · Journal of Neurochemistry
21. Valproic acid enhances microglial phagocytosis of amyloid-β1–42
    A.M. Smith, Hannah M. Gibbons, Mike Dragunow · 2010 · Neuroscience
22. Decrease in Blood Pressure and Regression of Cardiovascular Complications by Angiotensin II Vaccine in Mice
    Futoshi Nakagami, Hiroshi Koriyama, Hironori Nakagami, Mariana Kiomy Osako, Munehisa Shimamura, Mariko Kyutoku, Takashi Miyake, Tomohiro Katsuya, Hiromi Rakugi, Ryuichi Morishita · 2013 · PLoS ONE
23. Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease
    Kazuhiko Matsuo, Hideaki Okamoto, Yasuaki Kawai, Ying‐Shu Quan, Fumio Kamiyama, Sachiko Hirobe, Naoki Okada, Shinsaku Nakagawa · 2013 · Journal of Neuroimmunology
24. The Promises and Challenges of Erythropoietin for Treatment of Alzheimer’s Disease
    Jiahong Sun, Jan Michelle Martin, Victoria Vanderpoel, Rachita K. Sumbria · 2019 · NeuroMolecular Medicine
25. The role of Locus Coeruleus in neuroinflammation occurring in Alzheimer’s disease
    Filippo Sean Giorgi, Luigi Francesco Saccaro, Alessandro Galgani, Carla Letizia Busceti, Francesca Biagioni, Alessandro Frati, Francesco Fornai · 2019 · Brain Research Bulletin
26. Learning from the Past: A Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer’s Disease
    Kelly Ceyzériat, Thomas Zilli, P. Millet, Giovanni Battista Frisoni, Valentina Garibotto, Benjamin B. Tournier · 2020 · Current Alzheimer Research
27. Stress kinases involved inTau phosphorylation in alzheimer’s disease, tauopathies and APP transgenic mice
    Isidró Ferrer · 2004 · Neurotoxicity Research
28. Preconditioning and the developing brain
    Henrik Hagberg, Olaf Dammann, Carina E. Mallard, Alan Leviton · 2004 · Seminars in Perinatology
29. Anti-Amnesic and Neuroprotective Actions of the Sigma-1 Receptor Agonist (-)-MR22 in Rats with Selective Cholinergic Lesion and Amyloid Infusion
    Vuokko Antonini, Agostino Marrazzo, Giulio Kleiner, Marino Coradazzi, Simone Ronsisvalle, Orazio Prezzavento, Giuseppe Ronsisvalle, Giampiero Leanza · 2011 · Journal of Alzheimer s Disease
30. Neuropathology of Alzheimer's Disease
    Teresa Gómez‐Isla, Tara L. Spires‐Jones, Alix de Calignon, Bradley T. Hyman · 2008 · Handbook of clinical neurology
31. Suppressed Accumulation of Cerebral Amyloid β Peptides in Aged Transgenic Alzheimer’s Disease Mice by Transplantation with Wild-Type or Prostaglandin E2 Receptor Subtype 2-Null Bone Marrow
    Christopher Dirk Keene, Rubens C. Chang, Américo Harry López-Yglesias, Bryan Richard Shalloway, Izabella Sokal, Xianwu Li, Patrick Reed, Lisa M. Keene, Kathleen S. Montine, RICHARD M. BREYER et al. · 2010 · American Journal Of Pathology
32. Striking reduction of amyloid plaque burden in an Alzheimer's mouse model after chronic administration of carmustine
    Crystal D. Hayes, Debleena Dey, Juan Pablo Palavicini, Hongjie Wang, Kshitij A. Patkar, Dmitriy Minond, Adel Nefzi, Madepalli Krishnappa Lakshmana · 2013 · BMC Medicine
33. Alzheimer's Therapeutics: Translation of Preclinical Science to Clinical Drug Development
    Alena V. Savonenko, Tatiana Melnikova, Andrew Hiatt, Tong Li, Paul F. Worley, Juan Carlos Troncoso, Phil C Wong, Don L Price · 2011 · Neuropsychopharmacology
34. Crystal structure reveals conservation of amyloid-β conformation recognized by 3D6 following humanization to bapineuzumab
    Hadar Feinberg, José W. Saldanha, Linnea Diep, Amita S. Goel, Angela Widom, Geertruida M. Veldman, William I. Weis, Dale Schenk, Guriqbal S. Basi · 2014 · Alzheimer s Research & Therapy
35. Matrix metalloproteinase 9–mediated intracerebral hemorrhage induced by cerebral amyloid angiopathy
    Lingzhi Zhao, Michal Arbel‐Ornath, Xueying Wang, Rebecca A. Betensky, Steven Mark Greenberg, Matthew P. Frosch, Brian J. Bacskai · 2015 · Neurobiology of Aging
36. Tratamento farmacológico da doença de Alzheimer
    Orestes Vicente Forlenza · 2005 · Archives of Clinical Psychiatry (São Paulo)
37. Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disorders
    Rakez Kayed, George R. Jackson · 2009 · Current Opinion in Immunology
38. Neuronal and Nonneuronal Quantitative BACE Immunocytochemical Expression in the Entorhinohippocampal and Frontal Regions in Alzheimer’s Disease
    Geneviève Leuba, Gwenaëlle Wernli, André Vernay, Rudolf Kraftsik, M. Hasan Mohajeri, Krishan Saini · 2005 · Dementia and Geriatric Cognitive Disorders
39. Meningoencephalitis associated with passive immunization of a transgenic murine model of Alzheimer's amyloidosis
    Edward B. Lee, Lewis Z. Leng, Virginia M.‐Y. Lee, John Q. Trojanowski · 2005 · FEBS Letters
40. Curcumin: a natural substance with potential efficacy in Alzheimer’s disease
    Pamela E. Potter · 2013 · Journal of Experimental Pharmacology
41. Vaccination as a Therapeutic Approach to Alzheimer's Disease
    Thomas Wısnıewskı, Allal Boutajangout · 2010 · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine
42. Intracerebral immune complex formation induces inflammation in the brain that depends on Fc receptor interaction
    Jessica L. Teeling, Roxana Octavia Carare, Martin J. Glennie, Victor Hugh Perry · 2012 · Acta Neuropathologica
43. Efficacy and safety studies of gantenerumab in patients with Alzheimer’s disease
    Francesco Panza, Vincenzo Solfrizzi, Bruno Pietro Imbimbo, Michele Giannini, Andrea Santamato, Davide Seripa, Giancarlo Logroscino · 2014 · Expert Review of Neurotherapeutics
44. Papillomavirus-Like Particles Are an Effective Platform for Amyloid-β Immunization in Rabbits and Transgenic Mice
    Eduardo D. Zamora, Alessandra Handisurya, Saeed Shafti‐Keramat, David Borchelt, Gay L. Rudow, Katherine E. Conant, Christopher Cox, Juan Carlos Troncoso, Reinhard Kirnbauer · 2006 · The Journal of Immunology
45. Concepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application
    Claus U. Pietrzik, Christian Behl · 2005 · International Journal of Experimental Pathology
46. Brain and brawn
    Paula Isabel Moreira, K. Honda, Xiongwei Zhu, Akihiko Nunomura, Gemma Casadesús, Mark A. Smith, George L. Perry · 2006 · Neurology
47. A new role for astrocytes: β-amyloid homeostasis and degradation
    Nicoll, James A.R., Weller, Roy O. · 2003 · Trends in Molecular Medicine
48. Intramuscular delivery of a single chain antibody gene reduces brain Aβ burden in a mouse model of Alzheimer's disease
    Yan‐Jiang Wang, Anthony Pollard, Jinhua Zhong, Xiaoyan Dong, Xiaobing Wu, Huadong Zhou, Xin‐Fu Zhou · 2007 · Neurobiology of Aging
49. Alzheimer disease's double-edged vaccine
    Steven Mark Greenberg, Brian J. Bacskai, Bradley T. Hyman · 2003 · Nature Medicine
50. Human monoclonal antibodies against amyloid-beta from healthy adults
    Valeria Geylis, Vitaly Kourilov, Zeev Meiner, Inger Nennesmo, Nenad Bogdanović, Michael O Steinitz · 2004 · Neurobiology of Aging
51. Specificity of mechanisms for plaque removal after Aβ immunotherapy for Alzheimer disease
    Haruhiko Akiyama, Patrick L. McGeer · 2004 · Nature Medicine
52. Antibody Therapeutics Targeting Aβ and Tau
    Gilbert Gallardo, David M. Holtzman · 2017 · Cold Spring Harbor Perspectives in Medicine
53. Pathogenesis of Alzheimer Disease: Role of Oxidative Stress, Amyloid-β Peptides, Systemic Ammonia and Erythrocyte Energy Metabolism
    Elena A. Kosenko, Ilya Solomadin, Lyudmila A. Tikhonova, V. Prakash Reddy, Gjumrakch M. Aliev, Yury G. Kaminsky · 2013 · CNS & Neurological Disorders - Drug Targets
54. MER5101, a Novel Aβ1-15:DT Conjugate Vaccine, Generates a Robust Anti-Aβ Antibody Response and Attenuates Aβ Pathology and Cognitive Deficits in APPswe/PS1ΔE9 Transgenic Mice
    Bin Liu, Jeffrey L. Frost, Jing Sun, Hongjun Fu, Stephen Grimes, Peter Blackburn, Cynthia Ann Lemere · 2013 · Journal of Neuroscience
55. Immunotherapy against amyloid pathology in Alzheimer's disease
    Daniela Galimberti, Laura Ghezzi, Elio Angelo Scarpini · 2013 · Journal of the Neurological Sciences
56. Therapeutic vaccine against DPP4 improves glucose metabolism in mice
    Zheng‐Da Pang, Hironori Nakagami, Mariana Kiomy Osako, Hiroshi Koriyama, Futoshi Nakagami, Hideki Tomioka, Munehisa Shimamura, Hitomi Kurinami, Yoichi Takami, Ryuichi Morishita et al. · 2014 · Proceedings of the National Academy of Sciences
57. The therapeutic potential of the endocannabinoid system for Alzheimer's disease
    Tim Karl, David Cheng, Brett Garner, Jonathon Carl Arnold · 2012 · Expert Opinion on Therapeutic Targets
58. Immune complex formation impairs the elimination of solutes from the brain: implications for immunotherapy in Alzheimer’s disease
    Roxana Octavia Carare, Jessica L. Teeling, Cheryl A. Hawkes, Ursula Püntener, Roy O. Weller, James A. R. Nicoll, Victor Hugh Perry · 2013 · Acta Neuropathologica Communications
59. Pro-inflammatory conditions promote neuronal damage mediated by Amyloid Precursor Protein and decrease its phagocytosis and degradation by microglial cells in culture
    Rommy von Bernhardi M., Gigliola Ramírez, Rodrigo Toro, Jaime L. Eugenín · 2006 · Neurobiology of Disease
60. Dystrophic neurites in TgCRND8 and Tg2576 mice mimic human pathological brain aging
    Adele Woodhouse, James Clement Vickers, Paul Anthony Adlard, Tracey C. Dickson · 2007 · Neurobiology of Aging
61. Developing Preventive Therapies for Chronic Diseases: Lessons Learned from Alzheimer's Disease
    Dennis J. Selkoe · 2008 · Nutrition Reviews
62. The modular systems biology approach to investigate the control of apoptosis in Alzheimer's disease neurodegeneration
    Lilia Alberghina, Anna Maria Colangelo · 2006 · BMC Neuroscience
63. Overcoming antigen masking of anti-amyloidbeta antibodies reveals breaking of B cell tolerance by virus-like particles in amyloidbeta immunized amyloid precursor protein transgenic mice
    Qingyou Li, Chuanhai Cao, Bryce Chackerian, John T. Schiller, Marcia N. Gordon, Kenneth E. Ugen, David Morgan · 2004 · BMC Neuroscience
64. Microglia and immunotherapy in Alzheimer’s disease
    Qingqing Li, Yingying Wu, Jichun Chen, Aiguo Xuan, Xiao Wang · 2021 · Acta Neurologica Scandinavica
65. Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders
    Zi-Hua Guo, Saadullah Khattak, Mohd Ahmar Rauf, Mohammad Azam Ansari, Mohammad N. Alomary, Sufyan Razak, Changyong Yang, Dongdong Wu, Xin‐Ying Ji · 2023 · Molecules
66. Cerebral microbleeds in a multiethnic elderly community: Demographic and clinical correlates
    Anne F Wiegman, Irene B. Meier, Nicole Schupf, Jennifer Jaie Manly, Vanessa A. Guzman, Atul Narkhede, Yaakov Stern, Sergi Martínez‐Ramírez, Anand Viswanathan, Jose Alejandro Luchsinger et al. · 2014 · Journal of the Neurological Sciences
67. Cerebral amyloid angiopathy-related inflammation presenting with steroid-responsive higher brain dysfunction: case report and review of the literature
    Hideya Sakaguchi, Akihiko Ueda, Takayuki Kosaka, Satoshi Yamashita, En Kimura, Taro Yamashita, Yasushi Maeda, Teruyuki Hirano, Makoto Uchino · 2011 · Journal of Neuroinflammation
68. An update on treatment and prevention strategies for Alzheimer’s disease
    Judith A. Neugroschl, Mary Sano · 2009 · Current Neurology and Neuroscience Reports
69. Intracranial administration of deglycosylated C-terminal-specific anti-Aβ antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice
    Nikisha Carty, Donna M. Wilcock, Arnon Rosenthal, Jan Grimm, Jaume Pons, Victoria Ronan, Paul E. Gottschall, Marcia N. Gordon, David Morgan · 2006 · Journal of Neuroinflammation
70. Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials
    Petrushina, Irina, Hovakimyan, Armine, Harahap-Carrillo, Indira S., Davtyan, Hayk, Antonyan, Tatevik, Chailyan, Gor, Kazarian, Konstantin, Antonenko, Maxim, Jullienne, Amandine, Hamer, Mary M. et al. · 2020 · Neurobiology of Disease
71. Induction of Methionine-Sulfoxide Reductases Protects Neurons from Amyloid β-Protein Insults in Vitro and in Vivo
    Jackob Moskovitz, Panchanan Maiti, Dahabada H. J. Lopes, Derek B. Oien, Aida Attar, Tingyu Liu, Shivina Mittal, Jane Hayes, Gal Bitan · 2011 · Biochemistry
72. BEYOND AMYLOID: The Next Generation of Alzheimer's Disease Therapeutics
    Guy R. Seabrook, William J. Ray, M. S. Shearman, Melanie L. Hutton · 2007 · Molecular Interventions
73. Solanezumab for Alzheimer's disease
    Hossein Samadi, David L. Sultzer · 2011 · Expert Opinion on Biological Therapy
74. Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
    Jacqui Nimmo, Ajay Kumar Verma, Jean‐Cosme Dodart, Chang Yi Wang, Jimmy Savistchenko, Ronald Melki, Roxana Octavia Carare, James A. R. Nicoll · 2020 · Alzheimer s Research & Therapy
75. Experimental Investigation of Antibody-Mediated Clearance Mechanisms of Amyloid-β in CNS of Tg-SwDI Transgenic Mice
    Vitaly Vasilevko, Feng Xu, Mary Lou Previti, William E. Van Nostrand, David H. Cribbs · 2007 · Journal of Neuroscience
76. Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease
    Jaspreet Kalra, Aamir Ghafoor Khan · 2015 · European Journal of Pharmacology
77. Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice
    Frédérique Bard, Michael Fox, Stuart W. Friedrich, Peter A. Seubert, Dale Schenk, Gene G. Kinney, Ted A. Yednock · 2012 · Experimental Neurology
78. Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives
    Masashi Tanaka, Satoshi Saitô, Takayuki Inoue, Noriko Satoh‐Asahara, Masafumi Ihara · 2019 · International Journal of Molecular Sciences
79. Mouse models in neurological disorders: Applications of non-invasive imaging
    Yannic Waerzeggers, Parisa Monfared, Thomas Viel, Alexandra Winkeler, Andreas Hans Jacobs · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
80. Active β-Amyloid Immunization Restores Spatial Learning in PDAPP Mice Displaying Very Low Levels of β-Amyloid
    Guiquan Chen, Karen S Chen, Dione T. Kobayashi, Robin Barbour, Ruth N. Motter, Dora Games, Stephen J. Martin, Richard Morris · 2007 · Journal of Neuroscience
81. Reduced Pathology and Improved Behavioral Performance in Alzheimer's Disease Mice Vaccinated With HSV Amplicons Expressing Amyloid-β and Interleukin-4
    Maria E. Frazer, Jennifer E Hughes, Michael A. Mastrangelo, Jennifer L Tibbens, Howard J. Federoff, William J. Bowers · 2008 · Molecular Therapy
82. Increased T Cell Recruitment to the CNS after Amyloid β1–42Immunization in Alzheimer's Mice Overproducing Transforming Growth Factor-β1
    Marion S. Buckwalter, Bronwen S. Coleman, Manuel Buttini, Robin Barbour, Dale Schenk, Dora Games, Peter A. Seubert, Tony Wyss‐Coray · 2006 · Journal of Neuroscience
83. An anti-Aβ (amyloid β) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing Aβ oligomers from the amyloid pathway
    Marta Marin‐Argany, Geovanny Rivera-Hernández, Joaquı́n Martı́, Sandra Villegas · 2011 · Biochemical Journal
84. A Rapidly Progressive Dementia
    Andreas Charidimou, David John Werring · 2015 · Springer eBooks
85. Modulation of microglial activation state following passive immunization in amyloid depositing transgenic mice
    D MORGAN · 2006 · Neurochemistry International
86. Disease modifying strategies for the treatment of Alzheimer's disease targeted at modulating levels of the β-amyloid peptide
    Menelas N. Pangalos, Steve J. Jacobsen, Peter H. Reinhart · 2005 · Biochemical Society Transactions
87. The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update
    Kelly R. Bales · 2012 · Expert Opinion on Drug Discovery
88. Structural Correlates of Antibodies Associated with Acute Reversal of Amyloid β-related Behavioral Deficits in a Mouse Model of Alzheimer Disease
    Guriqbal S. Basi, Hadar Feinberg, Farshid Oshidari, John Anderson, Robin Barbour, Jeanne Baker, Thomas A. Comery, Linnea Diep, Davinder S. Gill, Kelly Johnson‐Wood et al. · 2009 · Journal of Biological Chemistry
89. Compensatory responses induced by oxidative stress in Alzheimer disease
    Paula Isabel Moreira, Xiongwei Zhu, Quan Liu, Kazuhiro Honda, Sandra L. Siedlak, Peggy L.R. Harris, Mark A. Smith, George L. Perry · 2006 · Biological Research
90. Mouse models of Alzheimer's disease: The long and filamentous road
    Amie L. Phinney, Patrick Horne, Jing Yang, Chris Janus, Catherine Bergeron, David A. Westaway · 2003 · Neurological Research
91. Intracerebroventricular passive immunization with anti‐Aβ antibody in Tg2576
    Neelima B. Chauhan, George J. Siegel · 2003 · Journal of Neuroscience Research
92. Hormone therapy and Alzheimer?s disease: benefit or harm?
    Victor W. Henderson · 2004 · Expert Opinion on Pharmacotherapy
93. Amyloidosis in Retinal Neurodegenerative Diseases
    Ambra Masuzzo, Virginie Dinet, Chelsea Cavanagh, Frédéric Mascarelli, Slavica M Krantic · 2016 · Frontiers in Neurology
94. Immunotherapy of Alzheimer's disease (AD): From murine models to anti-amyloid beta (Aβ) human monoclonal antibodies
    Valeria Geylis, Michael O Steinitz · 2005 · Autoimmunity Reviews
95. Effect of active A<i>β</i> immunotherapy on neurons in human Alzheimer's disease
    Paquet, Claire, Amin, Jay, Mouton‐Liger, François, Nasser, Mariam, Love, Seth, Gray, Françoise, Pickering, Ruth M, Nicoll, James AR, Holmes, Clive, Hugon, Jacques et al. · 2015 · The Journal of Pathology
96. P2Y receptors in Alzheimer's disease
    Laurie Erb, Cao Chen, Deepa Ajit, Gary A. Weisman · 2014 · Biology of the Cell
97. DNA prime–protein boost increased the titer, avidity and persistence of anti-Aβ antibodies in wild-type mice
    Hayk Davtyan, Mikayel Mkrtichyan, Nina Movsesyan, Irina Petrushina, Gregory Mamikonyan, David H. Cribbs, Michael G. Agadjanyan, Anahit Ghochikyan · 2009 · Gene Therapy
98. The biochemical aftermath of anti-amyloid immunotherapy
    Chera L. Maarouf, Ian D. Daugs, Tyler A. Kokjohn, Walter M. Kalback, Rebekah Patton, Dean C. Luehrs, Eliezer Masliah, James A. R. Nicoll, Marwan Noel Sabbagh, Thomas G. Beach et al. · 2010 · Molecular Neurodegeneration
99. Taxifolin: A Potential Therapeutic Agent for Cerebral Amyloid Angiopathy
    Satoshi Saitô, Masashi Tanaka, Noriko Satoh‐Asahara, Roxana Octavia Carare, Masafumi Ihara · 2021 · Frontiers in Pharmacology
100. Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Aβ1‐6 upregulates IL‐10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease
     Hong‐Duck Kim, Kazuki Tahara, J. Adam Maxwell, Robert Lalonde, Tatsuya Fukuiwa, Kohtaro Fujihashi, Kent R. Van Kampen, Fan-Kun Kong, De-chu Christopher Tang, Ken‐ichiro Fukuchi · 2007 · The Journal of Gene Medicine